Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 357 articles:
HTML format

Single Articles

    January 2021
  1. BARLASS U, Deshmukh A, Beck T, Bishehsari F, et al
    Opioid use as a potential risk factor for pancreatic cancer in the United States: An analysis of state and national level databases.
    PLoS One. 2021;16:e0244285.
    PubMed     Abstract available

  2. YOSHIOKA R, Imamura H, Ichida H, Gyoda Y, et al
    Simulation training in pancreatico-jejunostomy using an inanimate biotissue model improves the technical skills of hepatobiliary-pancreatic surgical fellows.
    PLoS One. 2021;16:e0244915.
    PubMed     Abstract available

  3. YABE SG, Fukuda S, Nishida J, Takeda F, et al
    Efficient induction of pancreatic alpha cells from human induced pluripotent stem cells by controlling the timing for BMP antagonism and activation of retinoic acid signaling.
    PLoS One. 2021;16:e0245204.
    PubMed     Abstract available

  4. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    PubMed     Abstract available

  5. XIE J, Peng Y, Chen X, Li Q, et al
    LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    PLoS One. 2021;16:e0245908.
    PubMed     Abstract available

  6. HOLLENBACH M, Sonnenberg S, Sommerer I, Lorenz J, et al
    Pitfalls in AR42J-model of cerulein-induced acute pancreatitis.
    PLoS One. 2021;16:e0242706.
    PubMed     Abstract available

  7. SOGAWA K, Takano S, Ishige T, Yoshitomi H, et al
    Usefulness of the MALDI-TOF MS technology with membrane filter protocol for the rapid identification of microorganisms in perioperative drainage fluids of hepatobiliary pancreatic surgery.
    PLoS One. 2021;16:e0246002.
    PubMed     Abstract available

  8. MUTHULINGAM JA, Olesen SS, Hansen TM, Brock C, et al
    Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham controlled clinical trial.
    PLoS One. 2021;16:e0247653.
    PubMed     Abstract available

  9. LI T, Zhao H, Zhou H, Geng T, et al
    LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
    PLoS One. 2021;16:e0247817.
    PubMed     Abstract available

  10. ZHANG C, Huang L, Xiong J, Xie L, et al
    Isoalantolactone inhibits pancreatic cancer proliferation by regulation of PI3K and Wnt signal pathway.
    PLoS One. 2021;16:e0247752.
    PubMed     Abstract available

  11. CAO H, Qiang L, Chen J, Johnson KM, et al
    Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells.
    PLoS One. 2021;16:e0248111.
    PubMed     Abstract available

  12. WEYHE D, Obonyo D, Uslar VN, Stricker I, et al
    Predictive factors for long-term survival after surgery for pancreatic ductal adenocarcinoma: Making a case for standardized reporting of the resection margin using certified cancer center data.
    PLoS One. 2021;16:e0248633.
    PubMed     Abstract available

  13. CHENG YH, Chiang EI, Syu JN, Chao CY, et al
    Treatment of 13-cis retinoic acid and 1,25-dihydroxyvitamin D3 inhibits TNF-alpha-mediated expression of MMP-9 protein and cell invasion through the suppression of JNK pathway and microRNA 221 in human pancreatic adenocarcinoma cancer cells.
    PLoS One. 2021;16:e0247550.
    PubMed     Abstract available

  14. SUGAWARA T, Ban D, Nishino J, Watanabe S, et al
    Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
    PLoS One. 2021;16:e0249885.
    PubMed     Abstract available

  15. ZHANG W, Sakoda H, Nakazato Y, Islam MN, et al
    Neuromedin U uses Galphai2 and Galphao to suppress glucose-stimulated Ca2+ signaling and insulin secretion in pancreatic beta cells.
    PLoS One. 2021;16:e0250232.
    PubMed     Abstract available

  16. ZHONG R, Jiang X, Peng Y, Xu H, et al
    A nomogram prediction of overall survival based on lymph node ratio, AJCC 8th staging system, and other factors for primary pancreatic cancer.
    PLoS One. 2021;16:e0249911.
    PubMed     Abstract available

    January 2020
  17. OHKUMA R, Yada E, Ishikawa S, Komura D, et al
    High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
    PLoS One. 2020;15:e0226707.
    PubMed     Abstract available

  18. PLAYFORD RJ, Marchbank T
    Pancreatic secretory trypsin inhibitor reduces multi-organ injury caused by gut ischemia/reperfusion in mice.
    PLoS One. 2020;15:e0227059.
    PubMed     Abstract available

  19. BROWN M, Zhang W, Yan D, Kenath R, et al
    The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC.
    PLoS One. 2020;15:e0226917.
    PubMed     Abstract available

  20. ANDO Y, Ohuchida K, Otsubo Y, Kibe S, et al
    Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5.
    PLoS One. 2020;15:e0228015.
    PubMed     Abstract available

  21. SINGH S, McDonald JT, Ilie G, Adisesh A, et al
    An examination of the association between lifetime history of prostate and pancreatic cancer diagnosis and occupation in a population sample of Canadians.
    PLoS One. 2020;15:e0227622.
    PubMed     Abstract available

  22. KHILJI MS, Verstappen D, Dahlby T, Burstein Prause MC, et al
    The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 beta.
    PLoS One. 2020;15:e0222432.
    PubMed     Abstract available

  23. Expression of Concern: Reduction in ATP Levels Triggers Immunoproteasome Activation by the 11S (PA28) Regulator during Early Antiviral Response Mediated by IFNbeta in Mouse Pancreatic beta-Cells.
    PLoS One. 2020;15:e0229516.

  24. SOLANKI A, King D, Thibault G, Wang L, et al
    Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systems.
    PLoS One. 2020;15:e0229407.
    PubMed     Abstract available

  25. USON PLS JUNIOR, Tolentino FDS, Santos VM, Rother ET, et al
    The impact of metastatic sites in advanced pancreatic adenocarcinoma, systematic review and meta-analysis of prospective randomized studies.
    PLoS One. 2020;15:e0230060.
    PubMed     Abstract available

  26. WOLFE D, Kanji S, Yazdi F, Barbeau P, et al
    Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.
    PLoS One. 2020;15:e0231883.
    PubMed     Abstract available

  27. FANCHON LM, Russell J, Pillarsetty N, O'Donoghue I, et al
    Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0231745.
    PubMed     Abstract available

  28. BUSTOS AS, Hakansson A, Linares-Pasten JA, Penarrieta JM, et al
    Interaction of quercetin and epigallocatechin gallate (EGCG) aggregates with pancreatic lipase under simplified intestinal conditions.
    PLoS One. 2020;15:e0224853.
    PubMed     Abstract available

  29. DEMIRKOL CANLI S, Dedeoglu E, Akbar MW, Kucukkaraduman B, et al
    A novel 20-gene prognostic score in pancreatic adenocarcinoma.
    PLoS One. 2020;15:e0231835.
    PubMed     Abstract available

  30. CHOW JPH, Cai Y, Chow DTL, Chung SHK, et al
    A modified arginine-depleting enzyme NEI-01 inhibits growth of pancreatic cancer cells.
    PLoS One. 2020;15:e0231633.
    PubMed     Abstract available

  31. LUO S, Lenon GB, Gill H, Hung A, et al
    Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic alpha-amylase activity: Enzymatic and in silico approaches.
    PLoS One. 2020;15:e0231815.
    PubMed     Abstract available

  32. TAKENAGA K, Akimoto M, Koshikawa N, Nagase H, et al
    Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model.
    PLoS One. 2020;15:e0232230.
    PubMed     Abstract available

  33. Retraction: Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer.
    PLoS One. 2020;15:e0233436.

  34. Expression of Concern: DUSP1 Is a Novel Target for Enhancing Pancreatic Cancer Cell Sensitivity to Gemcitabine.
    PLoS One. 2020;15:e0233098.

  35. LAI HC, Lee MS, Liu YT, Lin KT, et al
    Propofol-based intravenous anesthesia is associated with better survival than desflurane anesthesia in pancreatic cancer surgery.
    PLoS One. 2020;15:e0233598.
    PubMed     Abstract available

  36. HARADA N, Nomura M, Yoda Y, Matsumura S, et al
    Food texture affects glucose tolerance by altering pancreatic beta-cell function in mice consuming high-fructose corn syrup.
    PLoS One. 2020;15:e0233797.
    PubMed     Abstract available

  37. CHOU CK, Lee KC, Luo JC, Chen TS, et al
    Endoscopic papillary balloon dilatation less than three minutes for biliary stone removal increases the risk of post-ERCP pancreatitis.
    PLoS One. 2020;15:e0233388.
    PubMed     Abstract available

  38. SHINJO K, Hara K, Nagae G, Umeda T, et al
    A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
    PLoS One. 2020;15:e0233782.
    PubMed     Abstract available

  39. ABU-SHAWER O, Abu-Shawer M, Shurman A, Lattouf A, et al
    The clinical value of peripheral immune cell counts in pancreatic cancer.
    PLoS One. 2020;15:e0232043.
    PubMed     Abstract available

  40. KLAK M, Gomolka M, Dobrzanski T, Tymicki G, et al
    Irradiation with 365 nm and 405 nm wavelength shows differences in DNA damage of swine pancreatic islets.
    PLoS One. 2020;15:e0235052.
    PubMed     Abstract available

  41. UESATO Y, Sasahira N, Ozaka M, Sasaki T, et al
    Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis.
    PLoS One. 2020;15:e0235623.
    PubMed     Abstract available

  42. SATO K, Hikita H, Myojin Y, Fukumoto K, et al
    Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels.
    PLoS One. 2020;15:e0235573.
    PubMed     Abstract available

  43. SHINOURA S, Tokushige A, Chinen K, Mori H, et al
    Endosonographic finding of the simultaneous depiction of bile and pancreatic ducts can predict difficult biliary cannulation on endoscopic retrograde cholangiopancreatography.
    PLoS One. 2020;15:e0235757.
    PubMed     Abstract available

  44. SUZUKI Y, Takadate T, Mizuma M, Shima H, et al
    Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0235904.
    PubMed     Abstract available

  45. BOLM L, Zghurskyi P, Lapshyn H, Petrova E, et al
    Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology.
    PLoS One. 2020;15:e0234568.
    PubMed     Abstract available

  46. MOGENSEN PR, Grell K, Schmiegelow K, Overgaard UM, et al
    Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia.
    PLoS One. 2020;15:e0231209.
    PubMed     Abstract available

  47. MIYAKE H, Sakagami J, Yasuda H, Sogame Y, et al
    Correction: Association of fatty pancreas with pancreatic endocrine and exocrine function.
    PLoS One. 2020;15:e0236915.
    PubMed     Abstract available

  48. TAKAHASHI M, Shibasaki M, Echizen H, Kushiyama A, et al
    Comparisons between dipeptidyl peptidase-4 inhibitors and other classes of hypoglycemic drugs using two distinct biomarkers of pancreatic beta-cell function: A meta-analysis.
    PLoS One. 2020;15:e0236603.
    PubMed     Abstract available

  49. HAL WA, Straza MW, Chen X, Mickevicius N, et al
    Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0236570.
    PubMed     Abstract available

  50. XIE F, Chen Q, Zhou Y, Chen W, et al
    Characterization of patients with advanced chronic pancreatitis using natural language processing of radiology reports.
    PLoS One. 2020;15:e0236817.
    PubMed     Abstract available

  51. UHLEMEYER C, Muller N, Griess K, Wessel C, et al
    ATM and P53 differentially regulate pancreatic beta cell survival in Ins1E cells.
    PLoS One. 2020;15:e0237669.
    PubMed     Abstract available

  52. BERNARD B, Rajamanickam V, Dubay C, Piening B, et al
    Transcriptional and immunohistological assessment of immune infiltration in pancreatic cancer.
    PLoS One. 2020;15:e0238380.
    PubMed     Abstract available

  53. LEE J, Lee JC, Kim HW, Kim J, et al
    Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer.
    PLoS One. 2020;15:e0238649.
    PubMed     Abstract available

  54. MARGARYAN S, Kriegova E, Fillerova R, Smotkova Kraiczova V, et al
    Hypomethylation of IL1RN and NFKB1 genes is linked to the dysbalance in IL1beta/IL-1Ra axis in female patients with type 2 diabetes mellitus.
    PLoS One. 2020;15:e0233737.
    PubMed     Abstract available

  55. BOAS FE, Nurili F, Bendet A, Cheleuitte-Nieves C, et al
    Induction and characterization of pancreatic cancer in a transgenic pig model.
    PLoS One. 2020;15:e0239391.
    PubMed     Abstract available

  56. CHOI MH, Yoon SB, Song M, Lee IS, et al
    Benefits of the multiplanar and volumetric analyses of pancreatic cancer using computed tomography.
    PLoS One. 2020;15:e0240318.
    PubMed     Abstract available

  57. NWEKE EE, Naicker P, Aron S, Stoychev S, et al
    SWATH-MS based proteomic profiling of pancreatic ductal adenocarcinoma tumours reveals the interplay between the extracellular matrix and related intracellular pathways.
    PLoS One. 2020;15:e0240453.
    PubMed     Abstract available

  58. YAMAMOTO S, Nagamine Y, Miyashita T, Ito S, et al
    Perioperative and anesthetic risk factors of surgical site infection in patients undergoing pancreaticoduodenectomy: A retrospective cohort study.
    PLoS One. 2020;15:e0240490.
    PubMed     Abstract available

  59. PAVLIKOVA N, Sramek J, Jelinek M, Halada P, et al
    Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach.
    PLoS One. 2020;15:e0229430.
    PubMed     Abstract available

  60. CEBALLOS GA, Hernandez LF, Paredes D, Betancourt LR, et al
    A machine learning approach to predict pancreatic islet grafts rejection versus tolerance.
    PLoS One. 2020;15:e0241925.
    PubMed     Abstract available

  61. Correction: Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    PLoS One. 2020;15:e0242146.
    PubMed     Abstract available

  62. HUNG WC, Lee DY, Chiang EI, Syu JN, et al
    Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis.
    PLoS One. 2020;15:e0241186.
    PubMed     Abstract available

  63. THAKAR M, Hu Y, Morreale M, Lerner L, et al
    Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent.
    PLoS One. 2020;15:e0242974.
    PubMed     Abstract available

  64. SHEIKH M, Masoudi S, Bakhshandeh R, Moayyedkazemi A, et al
    Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study.
    PLoS One. 2020;15:e0243511.
    PubMed     Abstract available

  65. ROH YH, Kang BK, Song SY, Lee CM, et al
    Preoperative CT anthropometric measurements and pancreatic pathology increase risk for postoperative pancreatic fistula in patients following pancreaticoduodenectomy.
    PLoS One. 2020;15:e0243515.
    PubMed     Abstract available

  66. WOCHNER R, Clauss D, Nattenmuller J, Tjaden C, et al
    Impact of progressive resistance training on CT quantified muscle and adipose tissue compartments in pancreatic cancer patients.
    PLoS One. 2020;15:e0242785.
    PubMed     Abstract available

  67. DOI N, Ino Y, Angata K, Shimada K, et al
    Clinicopathological significance of core 3 O-glycan synthetic enzyme, beta1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0242851.
    PubMed     Abstract available

  68. GASTEIGER S, Primavesi F, Werkl P, Dostal L, et al
    The prognostic value of Presepsin for postoperative complications following pancreatic resection: A prospective study.
    PLoS One. 2020;15:e0243510.
    PubMed     Abstract available

  69. DUORUI N, Shi B, Zhang T, Chen C, et al
    The contemporary trend in worsening prognosis of pancreatic acinar cell carcinoma: A population-based study.
    PLoS One. 2020;15:e0243164.
    PubMed     Abstract available

  70. MAHARAJ AD, Evans SM, Zalcberg JR, Ioannou LJ, et al
    Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework.
    PLoS One. 2020;15:e0243312.
    PubMed     Abstract available

  71. LIN ZB, Song JY, Li AC, Chen C, et al
    The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis.
    PLoS One. 2020;15:e0243170.
    PubMed     Abstract available

  72. RAJPUT SA, Mirza MR, Choudhary MI
    Bergenin protects pancreatic beta cells against cytokine-induced apoptosis in INS-1E cells.
    PLoS One. 2020;15:e0241349.
    PubMed     Abstract available

  73. GRUBER ES, Jomrich G, Tamandl D, Gnant M, et al
    Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    PLoS One. 2020;15:e0244896.
    PubMed     Abstract available

  74. CHEN CY, Liang SH, Su YY, Chiang NJ, et al
    Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan.
    PLoS One. 2020;15:e0244487.
    PubMed     Abstract available

    January 2019
  75. KAISSIS GA, Lohofer FK, Ziegelmayer S, Danner J, et al
    Borderline-resectable pancreatic adenocarcinoma: Contour irregularity of the venous confluence in pre-operative computed tomography predicts histopathological infiltration.
    PLoS One. 2019;14:e0208717.
    PubMed     Abstract available

  76. MYSSAYEV A, Myssayev A, Ideguchi R, Eguchi S, et al
    Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.
    PLoS One. 2019;14:e0210178.
    PubMed     Abstract available

  77. COZZI L, Comito T, Fogliata A, Franzese C, et al
    Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma.
    PLoS One. 2019;14:e0210758.
    PubMed     Abstract available

  78. JIAO Y, Fu Z, Li Y, Zhang W, et al
    Aberrant FAM64A mRNA expression is an independent predictor of poor survival in pancreatic cancer.
    PLoS One. 2019;14:e0211291.
    PubMed     Abstract available

  79. GUNDERSON AJ, Yamazaki T, McCarty K, Phillips M, et al
    Blockade of fibroblast activation protein in combination with radiation treatment in murine models of pancreatic adenocarcinoma.
    PLoS One. 2019;14:e0211117.
    PubMed     Abstract available

  80. ADABLAH JE, Vinson R, Roper MG, Bertram R, et al
    Synchronization of pancreatic islets by periodic or non-periodic muscarinic agonist pulse trains.
    PLoS One. 2019;14:e0211832.
    PubMed     Abstract available

  81. REN S, Chen X, Wang Z, Zhao R, et al
    Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    PLoS One. 2019;14:e0211566.
    PubMed     Abstract available

  82. DE GAETANO A, Gaz C, Panunzi S
    Consistency of compact and extended models of glucose-insulin homeostasis: The role of variable pancreatic reserve.
    PLoS One. 2019;14:e0211331.
    PubMed     Abstract available

  83. CALVO-LERMA J, Fornes-Ferrer V, Peinado I, Heredia A, et al
    A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis.
    PLoS One. 2019;14:e0212459.
    PubMed     Abstract available

  84. RODELO-HAAD C, Aguera ML, Carmona A, Navarro MD, et al
    Pancreatic autoantibodies and CD14+CD16+ monocytes subset are associated with the impairment of ss-cell function after simultaneous pancreas-kidney transplantation.
    PLoS One. 2019;14:e0212547.
    PubMed     Abstract available

  85. Retraction: A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells.
    PLoS One. 2019;14:e0212884.

  86. AKBIB S, Stichelmans J, Stange G, Ling Z, et al
    Glucocorticoids and checkpoint tyrosine kinase inhibitors stimulate rat pancreatic beta cell proliferation differentially.
    PLoS One. 2019;14:e0212210.
    PubMed     Abstract available

  87. BRADLEY A, Van Der Meer R
    Neoadjuvant therapy versus upfront surgery for potentially resectable pancreatic cancer: A Markov decision analysis.
    PLoS One. 2019;14:e0212805.
    PubMed     Abstract available

  88. CALVO-LERMA J, Hulst J, Boon M, Colombo C, et al
    Clinical validation of an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy through a prospective interventional study in paediatric patients with Cystic Fibrosis.
    PLoS One. 2019;14:e0213216.
    PubMed     Abstract available

  89. DAVIS K, Dunseth CD, Mott SL, Cramer-Morales KL, et al
    Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I/II pancreatic ductal adenocarcinoma.
    PLoS One. 2019;14:e0213576.
    PubMed     Abstract available

  90. SINGHAL M, Khatibeghdami M, Principe DR, Mancinelli GE, et al
    TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth.
    PLoS One. 2019;14:e0211711.
    PubMed     Abstract available

  91. BAKKER GJ, Vanbellinghen MC, Scheithauer TP, Verchere CB, et al
    Pancreatic 18F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls.
    PLoS One. 2019;14:e0213202.
    PubMed     Abstract available

  92. BUTT SA, Lidegaard O, Skovlund C, Hannaford PC, et al
    Correction: Hormonal contraceptive use and risk of pancreatic cancer-A cohort study among premenopausal women.
    PLoS One. 2019;14:e0214771.
    PubMed     Abstract available

  93. CARSTENSEN-KIRBERG M, Rohrig K, Niersmann C, Ouwens DM, et al
    Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E.
    PLoS One. 2019;14:e0213650.
    PubMed     Abstract available

  94. POTEET E, Liu D, Liang Z, Van Buren G, et al
    Mesothelin and TGF-alpha predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib.
    PLoS One. 2019;14:e0213294.
    PubMed     Abstract available

  95. MOUHID L, Gomez de Cedron M, Garcia-Carrascosa E, Reglero G, et al
    Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer.
    PLoS One. 2019;14:e0214294.
    PubMed     Abstract available

  96. JUNG J, Yoon SM, Park JH, Seo DW, et al
    Stereotactic body radiation therapy for locally advanced pancreatic cancer.
    PLoS One. 2019;14:e0214970.
    PubMed     Abstract available

  97. YAMAMOTO KN, Nakamura A, Liu LL, Stein S, et al
    Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies.
    PLoS One. 2019;14:e0215409.
    PubMed     Abstract available

  98. GIAMPIERI R, Piva F, Occhipinti G, Bittoni A, et al
    Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy.
    PLoS One. 2019;14:e0215990.
    PubMed     Abstract available

  99. Correction: Retraction: A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells.
    PLoS One. 2019;14:e0216490.
    PubMed     Abstract available

  100. DYRLA P, Gil J, Kosik K, Schneditz D, et al
    Doppler tissue perfusion measurement is a sensitive and specific tool for a differentiation between malignant and inflammatory pancreatic tumors.
    PLoS One. 2019;14:e0215944.
    PubMed     Abstract available

  101. NAGAYA M, Hayashi A, Nakano K, Honda M, et al
    Distributions of endocrine cell clusters during porcine pancreatic development.
    PLoS One. 2019;14:e0216254.
    PubMed     Abstract available

  102. LIU CN, Chen S, Chen H, Yue L, et al
    Peak urea level, leukocyte count and use of invasive ventilation as risk factors of mortality in acute pancreatitis: A retrospective study.
    PLoS One. 2019;14:e0216562.
    PubMed     Abstract available

  103. MIYAZAKI Y, Murayama K, Fathi I, Imura T, et al
    Strategy towards tailored donor tissue-specific pancreatic islet isolation.
    PLoS One. 2019;14:e0216136.
    PubMed     Abstract available

  104. WEIS S, Heindl M, Carvalho T, Jentho E, et al
    Azithromycin does not improve disease severity in acute experimental pancreatitis.
    PLoS One. 2019;14:e0216614.
    PubMed     Abstract available

  105. GRUBER ES, Jomrich G, Tamandl D, Gnant M, et al
    Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    PLoS One. 2019;14:e0215915.
    PubMed     Abstract available

  106. YUAN J, Hasdemir B, Tan T, Chheda C, et al
    Protective effects of urocortin 2 against caerulein-induced acute pancreatitis.
    PLoS One. 2019;14:e0217065.
    PubMed     Abstract available

  107. HAO F, Xu Q, Wang J, Yu S, et al
    Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice.
    PLoS One. 2019;14:e0216603.
    PubMed     Abstract available

  108. YABE SG, Nishida J, Fukuda S, Takeda F, et al
    Expression of mutant mRNA and protein in pancreatic cells derived from MODY3- iPS cells.
    PLoS One. 2019;14:e0217110.
    PubMed     Abstract available

  109. ZHENG Z, Tan C, Chen Y, Ping J, et al
    Impact of different surgical procedures on survival outcomes of patients with adenocarcinoma of pancreatic neck.
    PLoS One. 2019;14:e0217427.
    PubMed     Abstract available

  110. TANIUCHI K, Furihata M, Naganuma S, Sakaguchi M, et al
    Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients.
    PLoS One. 2019;14:e0217920.
    PubMed     Abstract available

  111. ONYEAGHALA G, Lane J, Pankratz N, Nelson HH, et al
    Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study.
    PLoS One. 2019;14:e0217868.
    PubMed     Abstract available

  112. ALLEN A, Qin ACR, Raj N, Wang J, et al
    Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition.
    PLoS One. 2019;14:e0217399.
    PubMed     Abstract available

  113. LU CH, Chen WT, Hsieh CH, Kuo YY, et al
    Thermal cycling-hyperthermia in combination with polyphenols, epigallocatechin gallate and chlorogenic acid, exerts synergistic anticancer effect against human pancreatic cancer PANC-1 cells.
    PLoS One. 2019;14:e0217676.
    PubMed     Abstract available

  114. FELIX TF, Lopez Lapa RM, de Carvalho M, Bertoni N, et al
    MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma.
    PLoS One. 2019;14:e0217421.
    PubMed     Abstract available

  115. NUNES QM, Su D, Brownridge PJ, Simpson DM, et al
    The heparin-binding proteome in normal pancreas and murine experimental acute pancreatitis.
    PLoS One. 2019;14:e0217633.
    PubMed     Abstract available

  116. BAECKER A, Kim S, Risch HA, Nuckols TK, et al
    Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data.
    PLoS One. 2019;14:e0218580.
    PubMed     Abstract available

  117. AL-ADSANI A, Burke ZD, Eberhard D, Lawrence KL, et al
    Correction: Dexamethasone Treatment Induces the Reprogramming of Pancreatic Acinar Cells to Hepatocytes and Ductal Cells.
    PLoS One. 2019;14:e0219419.
    PubMed     Abstract available

  118. HSIEH PH, Su HY, Lin CY, Kang YN, et al
    Infection rate among nutritional therapies for acute pancreatitis: A systematic review with network meta-analysis of randomized controlled trials.
    PLoS One. 2019;14:e0219151.
    PubMed     Abstract available

  119. MARIN-CANAS S, Estil Les E, Llado L, San Jose P, et al
    Pancreatic ductal cells may have a negative effect on human islet transplantation.
    PLoS One. 2019;14:e0220064.
    PubMed     Abstract available

  120. LANKI M, Seppanen H, Mustonen H, Hagstrom J, et al
    Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer.
    PLoS One. 2019;14:e0219245.
    PubMed     Abstract available

  121. BAFNA K, Narayanan C, Chennubhotla SC, Doucet N, et al
    Nucleotide substrate binding characterization in human pancreatic-type ribonucleases.
    PLoS One. 2019;14:e0220037.
    PubMed     Abstract available

  122. D'ANGELO A, Sobhani N, Roviello G, Bagby S, et al
    Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma.
    PLoS One. 2019;14:e0219566.
    PubMed     Abstract available

  123. KRUGER D, Yako YY, Devar J, Lahoud N, et al
    Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy.
    PLoS One. 2019;14:e0221169.
    PubMed     Abstract available

  124. PRATT EPS, Harvey KE, Salyer AE, Hockerman GH, et al
    Regulation of cAMP accumulation and activity by distinct phosphodiesterase subtypes in INS-1 cells and human pancreatic beta-cells.
    PLoS One. 2019;14:e0215188.
    PubMed     Abstract available

  125. JINNO N, Hori Y, Naitoh I, Miyabe K, et al
    Predictive factors for the mortality of acute pancreatitis on admission.
    PLoS One. 2019;14:e0221468.
    PubMed     Abstract available

  126. LUU HN, Huang JY, Wang R, Adams-Haduch J, et al
    Association between leukocyte telomere length and the risk of pancreatic cancer: Findings from a prospective study.
    PLoS One. 2019;14:e0221697.
    PubMed     Abstract available

  127. MATSUDA Y, Inoue Y, Hiratsuka M, Kawakatsu S, et al
    Encapsulating fibrosis following neoadjuvant chemotherapy is correlated with outcomes in patients with pancreatic cancer.
    PLoS One. 2019;14:e0222155.
    PubMed     Abstract available

  128. JIANG W, Wang M, Jiang HZ, Chen GC, et al
    Meta-analysis of fish consumption and risk of pancreatic cancer in 13 prospective studies with 1.8 million participants.
    PLoS One. 2019;14:e0222139.
    PubMed     Abstract available

  129. JOHNSON BL, d'Alincourt Salazar M, Mackenzie-Dyck S, D'Apuzzo M, et al
    Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice.
    PLoS One. 2019;14:e0221810.
    PubMed     Abstract available

  130. AHN SH, Granger A, Rankin MM, Lam CJ, et al
    Tamoxifen suppresses pancreatic beta-cell proliferation in mice.
    PLoS One. 2019;14:e0214829.
    PubMed     Abstract available

  131. KANG JH, Jung MY, Leof EB
    B7-1 drives TGF-beta stimulated pancreatic carcinoma cell migration and expression of EMT target genes.
    PLoS One. 2019;14:e0222083.
    PubMed     Abstract available

  132. KELLAWAY SG, Mosinska K, Mohamed Z, Ryan A, et al
    Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism.
    PLoS One. 2019;14:e0222350.
    PubMed     Abstract available

  133. CHUANG YW, Huang ST, Yu TM, Li CY, et al
    Acute pancreatitis risk after kidney transplantation: Propensity score matching analysis of a national cohort.
    PLoS One. 2019;14:e0222169.
    PubMed     Abstract available

  134. BRADLEY A, Van der Meer R, McKay CJ
    A prognostic Bayesian network that makes personalized predictions of poor prognostic outcome post resection of pancreatic ductal adenocarcinoma.
    PLoS One. 2019;14:e0222270.
    PubMed     Abstract available

  135. GOOCH A, Zhang P, Hu Z, Loy Son N, et al
    Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using "Neo-Islets," aggregates of adipose stem and pancreatic islet cells (INAD 012-776).
    PLoS One. 2019;14:e0218688.
    PubMed     Abstract available

  136. WOLIN E, Mita A, Mahipal A, Meyer T, et al
    A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.
    PLoS One. 2019;14:e0221994.
    PubMed     Abstract available

  137. KAISSIS G, Ziegelmayer S, Lohofer F, Steiger K, et al
    A machine learning algorithm predicts molecular subtypes in pancreatic ductal adenocarcinoma with differential response to gemcitabine-based versus FOLFIRINOX chemotherapy.
    PLoS One. 2019;14:e0218642.
    PubMed     Abstract available

  138. KELLAWAY SG, Mosinska K, Mohamed Z, Ryan A, et al
    Correction: Increased proliferation and altered cell cycle regulation in pancreatic stem cells derived from patients with congenital hyperinsulinism.
    PLoS One. 2019;14:e0223999.
    PubMed     Abstract available

  139. SANKAR KS, Altamentova SM, Rocheleau JV
    Hypoxia induction in cultured pancreatic islets enhances endothelial cell morphology and survival while maintaining beta-cell function.
    PLoS One. 2019;14:e0222424.
    PubMed     Abstract available

  140. AIER I, Semwal R, Dhara A, Sen N, et al
    An integrated epigenome and transcriptome analysis identifies PAX2 as a master regulator of drug resistance in high grade pancreatic ductal adenocarcinoma.
    PLoS One. 2019;14:e0223554.
    PubMed     Abstract available

  141. KOBAYASHI M, Ryozawa S, Iwano H, Araki R, et al
    The usefulness of wire-guided endoscopic snare papillectomy for tumors of the major duodenal papilla.
    PLoS One. 2019;14:e0211019.
    PubMed     Abstract available

  142. KAUNE T, Hollenbach M, Keil B, Chen JM, et al
    Common variants in glyoxalase I do not increase chronic pancreatitis risk.
    PLoS One. 2019;14:e0222927.
    PubMed     Abstract available

  143. Expression of Concern: Cooperativity of Oncogenic K-Ras and Downregulated p16/INK4A in Human Pancreatic Tumorigenesis.
    PLoS One. 2019;14:e0225279.

  144. JANG E, Son M, Jang J, Lee IH, et al
    DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy.
    PLoS One. 2019;14:e0225095.
    PubMed     Abstract available

  145. KATO S, Iwasaki A, Kurita Y, Arimoto J, et al
    Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
    PLoS One. 2019;14:e0224921.
    PubMed     Abstract available

  146. KUBO K, Wadasaki K, Komichi D, Sasaki T, et al
    A single institution experience of the treatment of pancreatic ductal carcinoma: The demand and the role of radiation therapy.
    PLoS One. 2019;14:e0227305.
    PubMed     Abstract available

  147. PARK D, Shakya R, Koivisto C, Pitarresi JR, et al
    Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.
    PLoS One. 2019;14:e0226714.
    PubMed     Abstract available

  148. ALNAHDI A, John A, Raza H
    N-acetyl cysteine attenuates oxidative stress and glutathione-dependent redox imbalance caused by high glucose/high palmitic acid treatment in pancreatic Rin-5F cells.
    PLoS One. 2019;14:e0226696.
    PubMed     Abstract available

  149. ZHENG Z, Wang M, Tan C, Chen Y, et al
    Disparities in survival by stage after surgery between pancreatic head and body/tail in patients with nonmetastatic pancreatic cancer.
    PLoS One. 2019;14:e0226726.
    PubMed     Abstract available

  150. WATANABE F, Suzuki K, Tamaki S, Abe I, et al
    Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer.
    PLoS One. 2019;14:e0227366.
    PubMed     Abstract available

    January 2018
  151. ISHIKAWA-KAKIYA Y, Shiba M, Maruyama H, Kato K, et al
    Risk of pancreatitis after pancreatic duct guidewire placement during endoscopic retrograde cholangiopancreatography.
    PLoS One. 2018;13:e0190379.
    PubMed     Abstract available

  152. MIHAYLOV IB, Mellon EA, Yechieli R, Portelance L, et al
    Automated inverse optimization facilitates lower doses to normal tissue in pancreatic stereotactic body radiotherapy.
    PLoS One. 2018;13:e0191036.
    PubMed     Abstract available

  153. CHENG Y, Imanirad P, Jutooru I, Hedrick E, et al
    Role of metastasis-associated lung adenocarcinoma transcript-1 (MALAT-1) in pancreatic cancer.
    PLoS One. 2018;13:e0192264.
    PubMed     Abstract available

  154. COPELAND LA, Swendsen CS, Sears DM, MacCarthy AA, et al
    Association between triglyceride levels and cardiovascular disease in patients with acute pancreatitis.
    PLoS One. 2018;13:e0179998.
    PubMed     Abstract available

  155. ZABICKI B, Limphaibool N, Holstad MJV, Juszkat R, et al
    Endovascular management of pancreatitis-related pseudoaneurysms: A review of techniques.
    PLoS One. 2018;13:e0191998.
    PubMed     Abstract available

  156. DANILOV AV, Neupane D, Nagaraja AS, Feofanova EV, et al
    Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance.
    PLoS One. 2018;13:e0192927.
    PubMed     Abstract available

  157. WENDEL U, Persson N, Risinger C, Bengtsson E, et al
    A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer.
    PLoS One. 2018;13:e0191872.
    PubMed     Abstract available

  158. LEE HS, Chung MJ, Park JY, Bang S, et al
    Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis.
    PLoS One. 2018;13:e0190835.
    PubMed     Abstract available

  159. WANG S, Oestricker LZ, Wallendorf MJ, Sterl K, et al
    Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance.
    PLoS One. 2018;13:e0192441.
    PubMed     Abstract available

  160. WU ST, Williams CD, Grover PA, Moore LJ, et al
    Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004.
    PLoS One. 2018;13:e0193260.
    PubMed     Abstract available

  161. KUKITA Y, Ohkawa K, Takada R, Uehara H, et al
    Selective identification of somatic mutations in pancreatic cancer cells through a combination of next-generation sequencing of plasma DNA using molecular barcodes and a bioinformatic variant filter.
    PLoS One. 2018;13:e0192611.
    PubMed     Abstract available

  162. GUO W, Zhong K, Wei H, Nie C, et al
    Long non-coding RNA SPRY4-IT1 promotes cell proliferation and invasion by regulation of Cdc20 in pancreatic cancer cells.
    PLoS One. 2018;13:e0193483.
    PubMed     Abstract available

  163. LI J, Qu X, Tian J, Zhang JT, et al
    Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation.
    PLoS One. 2018;13:e0193318.
    PubMed     Abstract available

  164. CHITTIBOYINA S, Chen Z, Chiorean EG, Kamendulis LM, et al
    The role of the folate pathway in pancreatic cancer risk.
    PLoS One. 2018;13:e0193298.
    PubMed     Abstract available

  165. WHITE M, Freistaedter A, Jones GJB, Zervos E, et al
    Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer.
    PLoS One. 2018;13:e0193131.
    PubMed     Abstract available

  166. CHEN CH, Lin CL, Jeng LB
    Association between chronic pancreatitis and urolithiasis: A population-based cohort study.
    PLoS One. 2018;13:e0194019.
    PubMed     Abstract available

  167. MONMA H, Iida Y, Moritani T, Okimoto T, et al
    Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells.
    PLoS One. 2018;13:e0193990.
    PubMed     Abstract available

  168. SEKITA-HATAKEYAMA Y, Nishikawa T, Takeuchi M, Morita K, et al
    K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
    PLoS One. 2018;13:e0193692.
    PubMed     Abstract available

  169. QUINAULT A, Leloup C, Denwood G, Spiegelhalter C, et al
    Modulation of large dense core vesicle insulin content mediates rhythmic hormone release from pancreatic beta cells over the 24h cycle.
    PLoS One. 2018;13:e0193882.
    PubMed     Abstract available

  170. KIM HY, Wang X, Kang R, Tang D, et al
    RAGE-specific single chain Fv for PET imaging of pancreatic cancer.
    PLoS One. 2018;13:e0192821.
    PubMed     Abstract available

  171. GERMINO EA, Miller JP, Diehl L, Swanson CJ, et al
    Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer.
    PLoS One. 2018;13:e0194998.
    PubMed     Abstract available

  172. XI T, Zhang G
    Integrated analysis of tumor differentiation genes in pancreatic adenocarcinoma.
    PLoS One. 2018;13:e0193427.
    PubMed     Abstract available

  173. SHEBANITS K, Andersson-Assarsson JC, Larsson I, Carlsson LMS, et al
    Copy number of pancreatic polypeptide receptor gene NPY4R correlates with body mass index and waist circumference.
    PLoS One. 2018;13:e0194668.
    PubMed     Abstract available

  174. IRIGOYEN A, Jimenez-Luna C, Benavides M, Caba O, et al
    Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers.
    PLoS One. 2018;13:e0194844.
    PubMed     Abstract available

  175. GURNEY-CHAMPION OJ, Klaassen R, Froeling M, Barbieri S, et al
    Comparison of six fit algorithms for the intra-voxel incoherent motion model of diffusion-weighted magnetic resonance imaging data of pancreatic cancer patients.
    PLoS One. 2018;13:e0194590.
    PubMed     Abstract available

  176. NIAZI MKK, Tavolara TE, Arole V, Hartman DJ, et al
    Identifying tumor in pancreatic neuroendocrine neoplasms from Ki67 images using transfer learning.
    PLoS One. 2018;13:e0195621.
    PubMed     Abstract available

  177. CORSELLO A, Di Filippo L, Massironi S, Sileo F, et al
    Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
    PLoS One. 2018;13:e0196858.
    PubMed     Abstract available

  178. STRETCH C, Aubin JM, Mickiewicz B, Leugner D, et al
    Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.
    PLoS One. 2018;13:e0196235.
    PubMed     Abstract available

  179. SAMBATHKUMAR R, Akkerman R, Dastidar S, Roelandt P, et al
    Generation of hepatocyte- and endocrine pancreatic-like cells from human induced endodermal progenitor cells.
    PLoS One. 2018;13:e0197046.
    PubMed     Abstract available

  180. HUANG JY, Butler LM, Midttun O, Ulvik A, et al
    A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer.
    PLoS One. 2018;13:e0196465.
    PubMed     Abstract available

  181. ZHANG D, Liu Y, Tang Y, Wang X, et al
    Increased mitochondrial fission is critical for hypoxia-induced pancreatic beta cell death.
    PLoS One. 2018;13:e0197266.
    PubMed     Abstract available

  182. MOTOYAMA H, Kobayashi A, Yokoyama T, Shimizu A, et al
    Treatment with specific soluble factors promotes the functional maturation of transcription factor-mediated, pancreatic transdifferentiated cells.
    PLoS One. 2018;13:e0197175.
    PubMed     Abstract available

  183. FUJIOKA R, Mochizuki N, Ikeda M, Sato A, et al
    Change in plasma lactate concentration during arctigenin administration in a phase I clinical trial in patients with gemcitabine-refractory pancreatic cancer.
    PLoS One. 2018;13:e0198219.
    PubMed     Abstract available

  184. DANESHMANESH AH, Hojjat-Farsangi M, Ghaderi A, Moshfegh A, et al
    A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.
    PLoS One. 2018;13:e0198038.
    PubMed     Abstract available

  185. OSAWA M
    A repetitive mutation and selection system for bacterial evolution to increase the specific affinity to pancreatic cancer cells.
    PLoS One. 2018;13:e0198157.
    PubMed     Abstract available

  186. RAO DD, Luo X, Wang Z, Jay CM, et al
    KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex.
    PLoS One. 2018;13:e0193644.
    PubMed     Abstract available

  187. ALAHMARI AA, Sreekumar B, Patel V, Ashat M, et al
    Cigarette toxin 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces experimental pancreatitis through alpha7 nicotinic acetylcholine receptors (nAChRs) in mice.
    PLoS One. 2018;13:e0197362.
    PubMed     Abstract available

  188. LU R, Yang J, Wei R, Ke J, et al
    Synergistic anti-tumor effects of liraglutide with metformin on pancreatic cancer cells.
    PLoS One. 2018;13:e0198938.
    PubMed     Abstract available

  189. TIEFTRUNK E, Demir IE, Schorn S, Sargut M, et al
    Pancreatic stump closure techniques and pancreatic fistula formation after distal pancreatectomy: Meta-analysis and single-center experience.
    PLoS One. 2018;13:e0197553.
    PubMed     Abstract available

  190. HAO L, Wang LS, Liu Y, Wang T, et al
    The different course of alcoholic and idiopathic chronic pancreatitis: A long-term study of 2,037 patients.
    PLoS One. 2018;13:e0198365.
    PubMed     Abstract available

  191. THAKAR M, Hu Y, Morreale M, Lerner L, et al
    A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent.
    PLoS One. 2018;13:e0199130.
    PubMed     Abstract available

  192. BHANDARI S, Abdul MKM, Hollabaugh W, Sharma K, et al
    Decreased trend in hospital mortality from pancreatic cancer despite increase in number of hospital admissions.
    PLoS One. 2018;13:e0199909.
    PubMed     Abstract available

  193. SCHMAHL MJ, Regan DP, Rivers AC, Joesten WC, et al
    NMR-based metabolic profiling of urine, serum, fecal, and pancreatic tissue samples from the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer.
    PLoS One. 2018;13:e0200658.
    PubMed     Abstract available

  194. ENGJOM T, Kavaliauskiene G, Tjora E, Erchinger F, et al
    Sonographic pancreas echogenicity in cystic fibrosis compared to exocrine pancreatic function and pancreas fat content at Dixon-MRI.
    PLoS One. 2018;13:e0201019.
    PubMed     Abstract available

  195. HOLLENBACH M, Kloting N, Sommerer I, Lorenz J, et al
    p8 deficiency leads to elevated pancreatic beta cell mass but does not contribute to insulin resistance in mice fed with high-fat diet.
    PLoS One. 2018;13:e0201159.
    PubMed     Abstract available

  196. VIEIRA A, Vergoni B, Courtney M, Druelle N, et al
    Neurog3 misexpression unravels mouse pancreatic ductal cell plasticity.
    PLoS One. 2018;13:e0201536.
    PubMed     Abstract available

  197. RAMAN P, Maddipati R, Lim KH, Tozeren A, et al
    Pancreatic cancer survival analysis defines a signature that predicts outcome.
    PLoS One. 2018;13:e0201751.
    PubMed     Abstract available

  198. KIRKEGARD J, Ladekarl M, Fristrup CW, Hansen CP, et al
    Urban versus rural residency and pancreatic cancer survival: A Danish nationwide population-based cohort study.
    PLoS One. 2018;13:e0202486.
    PubMed     Abstract available

  199. INNOCENTI F, Owzar K, Jiang C, Etheridge AS, et al
    The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation.
    PLoS One. 2018;13:e0202272.
    PubMed     Abstract available

  200. PARK YS, Jun IG, Go Y, Song JG, et al
    Comparison of acute kidney injury between open and laparoscopic pylorus-preserving pancreaticoduodenectomy: Propensity score analysis.
    PLoS One. 2018;13:e0202980.
    PubMed     Abstract available

  201. GONG Y, Zhang L, Zhang A, Chen X, et al
    GATA4 inhibits cell differentiation and proliferation in pancreatic cancer.
    PLoS One. 2018;13:e0202449.
    PubMed     Abstract available

  202. CURRAN AM, Scott-Boyer MP, Kaput J, Ryan MF, et al
    A proteomic signature that reflects pancreatic beta-cell function.
    PLoS One. 2018;13:e0202727.
    PubMed     Abstract available

  203. SEROUSSI E, Blum SE, Krifucks O, Lavon Y, et al
    Application of pancreatic phospholipase A2 for treatment of bovine mastitis.
    PLoS One. 2018;13:e0203132.
    PubMed     Abstract available

  204. NAKATOCHI M, Lin Y, Ito H, Hara K, et al
    Prediction model for pancreatic cancer risk in the general Japanese population.
    PLoS One. 2018;13:e0203386.
    PubMed     Abstract available

  205. MARTIN AN, Narayanan S, Turrentine FE, Bauer TW, et al
    Pancreatic duct size and gland texture are associated with pancreatic fistula after pancreaticoduodenectomy but not after distal pancreatectomy.
    PLoS One. 2018;13:e0203841.
    PubMed     Abstract available

  206. HWANG IC, Chang J, Park SM
    Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study.
    PLoS One. 2018;13:e0203918.
    PubMed     Abstract available

  207. SPINELLA G, Dondi F, Grassato L, Magna L, et al
    Prognostic value of canine pancreatic lipase immunoreactivity and lipase activity in dogs with gastric dilatation-volvulus.
    PLoS One. 2018;13:e0204216.
    PubMed     Abstract available

  208. Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer.
    PLoS One. 2018;13:e0205300.

  209. Retraction: Activated K-ras and INK4a/Arf Deficiency Cooperate During the Development of Pancreatic Cancer by Activation of Notch and NF-kappaB Signaling Pathways.
    PLoS One. 2018;13:e0205289.

  210. MAHMOUD AI, Galdos FX, Dinan KA, Jedrychowski MP, et al
    Apolipoprotein E is a pancreatic extracellular factor that maintains mature beta-cell gene expression.
    PLoS One. 2018;13:e0204595.
    PubMed     Abstract available

  211. HUTTNER FJ, Probst P, Kenngott HG, Knebel P, et al
    2-octyl cyanoacrylate sealing of the pancreatic remnant after distal pancreatectomy - A prospective pilot study.
    PLoS One. 2018;13:e0205748.
    PubMed     Abstract available

  212. AVANESOV M, Loser A, Smagarynska A, Keller S, et al
    Clinico-radiological comparison and short-term prognosis of single acute pancreatitis and recurrent acute pancreatitis including pancreatic volumetry.
    PLoS One. 2018;13:e0206062.
    PubMed     Abstract available

  213. ALECSANDRU D, Barrio A, Andia V, Cruz E, et al
    Pancreatic autoimmunity: An unknown etiology on patients with assisted reproductive techniques (ART)-recurrent reproductive failure.
    PLoS One. 2018;13:e0203446.
    PubMed     Abstract available

  214. LINTON SS, Abraham T, Liao J, Clawson GA, et al
    Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages.
    PLoS One. 2018;13:e0206759.
    PubMed     Abstract available

  215. HANDGRAAF HJM, Sibinga Mulder BG, Shahbazi Feshtali S, Boogerd LSF, et al
    Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer.
    PLoS One. 2018;13:e0205960.
    PubMed     Abstract available

  216. RYU GR, Lee E, Kim JJ, Moon SD, et al
    Comparison of enteroendocrine cells and pancreatic beta-cells using gene expression profiling and insulin gene methylation.
    PLoS One. 2018;13:e0206401.
    PubMed     Abstract available

  217. ABU-EL-HAIJA M, Hornung L, Denson LA, Husami A, et al
    Prevalence of abnormal glucose metabolism in pediatric acute, acute recurrent and chronic pancreatitis.
    PLoS One. 2018;13:e0204979.
    PubMed     Abstract available

  218. BUTT SA, Lidegaardi O, Skovlund C, Hannaford PC, et al
    Hormonal contraceptive use and risk of pancreatic cancer-A cohort study among premenopausal women.
    PLoS One. 2018;13:e0206358.
    PubMed     Abstract available

  219. SCHLICK K, Magnes T, Ratzinger L, Jaud B, et al
    Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
    PLoS One. 2018;13:e0206688.
    PubMed     Abstract available

  220. NEMETH BC, Pesei ZG, Hegyi E, Szucs A, et al
    The common truncation variant in pancreatic lipase related protein 2 (PNLIPRP2) is expressed poorly and does not alter risk for chronic pancreatitis.
    PLoS One. 2018;13:e0206869.
    PubMed     Abstract available

  221. WAKABAYASHI M, Futagami S, Yamawaki H, Tatsuguchi A, et al
    Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients.
    PLoS One. 2018;13:e0205165.
    PubMed     Abstract available

  222. WU Q, Fu M, Zheng K, Bo H, et al
    Elevated triglycerides level in hospital stay as a risk factor of mortality in patients with severe acute pancreatitis.
    PLoS One. 2018;13:e0207875.
    PubMed     Abstract available

  223. MORI T, Hamaya Y, Uotani T, Yamade M, et al
    Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma.
    PLoS One. 2018;13:e0208557.
    PubMed     Abstract available

  224. MIYAKE H, Sakagami J, Yasuda H, Sogame Y, et al
    Association of fatty pancreas with pancreatic endocrine and exocrine function.
    PLoS One. 2018;13:e0209448.
    PubMed     Abstract available

  225. DANIEL SK, Thornblade LW, Mann GN, Park JO, et al
    Standardization of perioperative care facilitates safe discharge by postoperative day five after pancreaticoduodenectomy.
    PLoS One. 2018;13:e0209608.
    PubMed     Abstract available

  226. ABOU ALI E, Bordacahar B, Mestas JL, Batteux F, et al
    Ultrasonic cavitation induces necrosis and impairs growth in three-dimensional models of pancreatic ductal adenocarcinoma.
    PLoS One. 2018;13:e0209094.
    PubMed     Abstract available

  227. MASU T, Atsukawa M, Nakatsuka K, Shimizu M, et al
    Anti-CD137 monoclonal antibody enhances trastuzumab-induced, natural killer cell-mediated cytotoxicity against pancreatic cancer cell lines with low human epidermal growth factor-like receptor 2 expression.
    PLoS One. 2018;13:e0200664.
    PubMed     Abstract available

  228. LIMA JG, Nobrega LHC, Lima NN, Dos Santos MCF, et al
    Causes of death in patients with Berardinelli-Seip congenital generalized lipodystrophy.
    PLoS One. 2018;13:e0199052.
    PubMed     Abstract available

    January 2017
  229. YOUNS M, Abdel Halim Hegazy W
    The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
    PLoS One. 2017;12:e0169335.
    PubMed     Abstract available

  230. ULLENHAG GJ, Mozaffari F, Broberg M, Mellstedt H, et al
    Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer.
    PLoS One. 2017;12:e0169736.
    PubMed     Abstract available

  231. ERCHINGER F, Engjom T, Jurmy P, Tjora E, et al
    Fecal Fat Analyses in Chronic Pancreatitis Importance of Fat Ingestion before Stool Collection.
    PLoS One. 2017;12:e0169993.
    PubMed     Abstract available

  232. JAHNY E, Yang H, Liu B, Jahnke B, et al
    The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation.
    PLoS One. 2017;12:e0170390.
    PubMed     Abstract available

  233. WENDT A, Mollet IG, Knutsson A, Bolmgren VS, et al
    Osteopontin Affects Insulin Vesicle Localization and Ca2+ Homeostasis in Pancreatic Beta Cells from Female Mice.
    PLoS One. 2017;12:e0170498.
    PubMed     Abstract available

  234. NELSON N, Szekeres K, Iclozan C, Rivera IO, et al
    Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.
    PLoS One. 2017;12:e0170197.
    PubMed     Abstract available

  235. LV X, Qiao W, Leng Y, Wu L, et al
    Impact of diabetes mellitus on clinical outcomes of pancreatic cancer after surgical resection: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0171370.
    PubMed     Abstract available

  236. SZUCS A, Marjai T, Szentesi A, Farkas N, et al
    Chronic pancreatitis: Multicentre prospective data collection and analysis by the Hungarian Pancreatic Study Group.
    PLoS One. 2017;12:e0171420.
    PubMed     Abstract available

  237. ETXEBERRIA J, Goicoa T, Lopez-Abente G, Riebler A, et al
    Spatial gender-age-period-cohort analysis of pancreatic cancer mortality in Spain (1990-2013).
    PLoS One. 2017;12:e0169751.
    PubMed     Abstract available

  238. LIU Q, Stewart J, Wang H, Rashid A, et al
    Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma.
    PLoS One. 2017;12:e0171985.
    PubMed     Abstract available

  239. VAN ARENSBERGEN J, Dussaud S, Pardanaud-Glavieux C, Garcia-Hurtado J, et al
    A distal intergenic region controls pancreatic endocrine differentiation by acting as a transcriptional enhancer and as a polycomb response element.
    PLoS One. 2017;12:e0171508.
    PubMed     Abstract available

  240. ALEKSEEVA LA, Mironova NL, Brenner EV, Kurilshikov AM, et al
    Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment.
    PLoS One. 2017;12:e0171988.
    PubMed     Abstract available

  241. JO YH, Kim SB, Liu Q, Do SG, et al
    Comparison of pancreatic lipase inhibitory isoflavonoids from unripe and ripe fruits of Cudrania tricuspidata.
    PLoS One. 2017;12:e0172069.
    PubMed     Abstract available

  242. XIA T, Zhou JY, Mou YP, Xu XW, et al
    Risk factors for postoperative pancreatic fistula after laparoscopic distal pancreatectomy using stapler closure technique from one single surgeon.
    PLoS One. 2017;12:e0172857.
    PubMed     Abstract available

  243. CHONG JU, Hwang HK, Lee JH, Yun M, et al
    Clinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.
    PLoS One. 2017;12:e0172606.
    PubMed     Abstract available

  244. MAHMUD M, Piwoni A, Filipczak N, Janicka M, et al
    Correction: Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
    PLoS One. 2017;12:e0173728.
    PubMed     Abstract available

  245. DHAYAT SA, Mirgorod P, Lenschow C, Senninger N, et al
    Challenges in pancreatic adenocarcinoma surgery - National survey and current practice guidelines.
    PLoS One. 2017;12:e0173374.
    PubMed     Abstract available

  246. KIM HW, Lee JC, Lee J, Kim JW, et al
    Early versus delayed initiation of adjuvant treatment for pancreatic cancer.
    PLoS One. 2017;12:e0173960.
    PubMed     Abstract available

  247. HSU FG, Hsieh YW, Sheu MJ, Lin CC, et al
    Tamoxifen use and acute pancreatitis: A population-based cohort study.
    PLoS One. 2017;12:e0173089.
    PubMed     Abstract available

  248. Expression of Concern: Concomitant Targeting of Multiple Key Transcription Factors Effectively Disrupts Cancer Stem Cells Enriched in Side Population of Human Pancreatic Cancer Cells.
    PLoS One. 2017;12:e0174194.

  249. JAMES PD, Meng ZW, Zhang M, Belletrutti PJ, et al
    The incremental benefit of EUS for identifying unresectable disease among adults with pancreatic adenocarcinoma: A meta-analysis.
    PLoS One. 2017;12:e0173687.
    PubMed     Abstract available

  250. TROUVE P, Genin E, Ferec C
    In silico search for modifier genes associated with pancreatic and liver disease in Cystic Fibrosis.
    PLoS One. 2017;12:e0173822.
    PubMed     Abstract available

  251. STRATFORD JK, Yan F, Hill RA, Major MB, et al
    Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability.
    PLoS One. 2017;12:e0174863.
    PubMed     Abstract available

  252. YAN T, Ke Y, Chen Y, Xu C, et al
    Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.
    PLoS One. 2017;12:e0174735.
    PubMed     Abstract available

  253. ZHU J, Wu J, Pei X, Tan Z, et al
    Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
    PLoS One. 2017;12:e0175039.
    PubMed     Abstract available

  254. DICKERSON MT, Vierra NC, Milian SC, Dadi PK, et al
    Osteopontin activates the diabetes-associated potassium channel TALK-1 in pancreatic beta-cells.
    PLoS One. 2017;12:e0175069.
    PubMed     Abstract available

  255. LIU S, Du F, Li X, Wang M, et al
    Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic beta cells.
    PLoS One. 2017;12:e0175498.
    PubMed     Abstract available

  256. VAN MANEN L, Stegehuis PL, Farina-Sarasqueta A, de Haan LM, et al
    Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens.
    PLoS One. 2017;12:e0175862.
    PubMed     Abstract available

  257. Correction: CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias.
    PLoS One. 2017;12:e0176804.
    PubMed     Abstract available

  258. CHEN J, Huang C, Wang J, Zhou H, et al
    Dysbiosis of intestinal microbiota and decrease in paneth cell antimicrobial peptide level during acute necrotizing pancreatitis in rats.
    PLoS One. 2017;12:e0176583.
    PubMed     Abstract available

  259. KANG JH, Park JS, Yu JS, Chung JJ, et al
    Prediction of pancreatic fistula after pancreatoduodenectomy by preoperative dynamic CT and fecal elastase-1 levels.
    PLoS One. 2017;12:e0177052.
    PubMed     Abstract available

  260. MA L, Saiyin H
    LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer.
    PLoS One. 2017;12:e0176844.
    PubMed     Abstract available

  261. HEBER SD, Hetterich H, Lorbeer R, Bayerl C, et al
    Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease.
    PLoS One. 2017;12:e0177154.
    PubMed     Abstract available

  262. PHILLIP V, Schwab M, Haf D, Algul H, et al
    Identification of risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis in a high volume center.
    PLoS One. 2017;12:e0177874.
    PubMed     Abstract available

  263. CHEN X, Oshima K, Schott D, Wu H, et al
    Assessment of treatment response during chemoradiation therapy for pancreatic cancer based on quantitative radiomic analysis of daily CTs: An exploratory study.
    PLoS One. 2017;12:e0178961.
    PubMed     Abstract available

  264. SONG W, Tian C, Wang K, Zhang RJ, et al
    Preoperative platelet lymphocyte ratio as independent predictors of prognosis in pancreatic cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0178762.
    PubMed     Abstract available

  265. IWATA T, Uchino T, Koyama A, Johmura Y, et al
    The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
    PLoS One. 2017;12:e0178221.
    PubMed     Abstract available

  266. VELEZ-SERRANO JF, Velez-Serrano D, Hernandez-Barrera V, Jimenez-Garcia R, et al
    Prediction of in-hospital mortality after pancreatic resection in pancreatic cancer patients: A boosting approach via a population-based study using health administrative data.
    PLoS One. 2017;12:e0178757.
    PubMed     Abstract available

  267. GEBAUER F, Kemper M, Sauter G, Prehm P, et al
    Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
    PLoS One. 2017;12:e0178703.
    PubMed     Abstract available

  268. MASINI M, Marselli L, Himpe E, Martino L, et al
    Co-localization of acinar markers and insulin in pancreatic cells of subjects with type 2 diabetes.
    PLoS One. 2017;12:e0179398.
    PubMed     Abstract available

  269. LIN SY, Hsu WH, Lin CC, Lin CL, et al
    Effect of acute pancreatitis on the risk of developing osteoporosis: A nationwide cohort study.
    PLoS One. 2017;12:e0179358.
    PubMed     Abstract available

  270. PANZUTO F, Cicchese N, Partelli S, Rinzivillo M, et al
    Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms.
    PLoS One. 2017;12:e0179445.
    PubMed     Abstract available

  271. IINO C, Shimoyama T, Igarashi T, Aihara T, et al
    Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer.
    PLoS One. 2017;12:e0178777.
    PubMed     Abstract available

  272. FEYGENZON V, Loewenstein S, Lubezky N, Pasmanic-Chor M, et al
    Unique cellular interactions between pancreatic cancer cells and the omentum.
    PLoS One. 2017;12:e0179862.
    PubMed     Abstract available

  273. JO JH, Cho IR, Jung JH, Lee HS, et al
    Clinical characteristics of second primary pancreatic cancer.
    PLoS One. 2017;12:e0179784.
    PubMed     Abstract available

  274. YANG SH, Lee JC, Guo JC, Kuo SH, et al
    Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy.
    PLoS One. 2017;12:e0180628.
    PubMed     Abstract available

  275. OGATA T, Nakamura M, Sang M, Yoda H, et al
    Depletion of runt-related transcription factor 2 (RUNX2) enhances SAHA sensitivity of p53-mutated pancreatic cancer cells through the regulation of mutant p53 and TAp63.
    PLoS One. 2017;12:e0179884.
    PubMed     Abstract available

  276. NAUMANN P, Liermann J, Fortunato F, Schmid TE, et al
    Sulforaphane enhances irradiation effects in terms of perturbed cell cycle progression and increased DNA damage in pancreatic cancer cells.
    PLoS One. 2017;12:e0180940.
    PubMed     Abstract available

  277. BEGUM A, Ewachiw T, Jung C, Huang A, et al
    The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
    PLoS One. 2017;12:e0180181.
    PubMed     Abstract available

  278. KUEN J, Darowski D, Kluge T, Majety M, et al
    Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model.
    PLoS One. 2017;12:e0182039.
    PubMed     Abstract available

  279. LU L, Zeng J
    Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.
    PLoS One. 2017;12:e0181532.
    PubMed     Abstract available

  280. GARCIA TS, Rech TH, Leitao CB
    Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies.
    PLoS One. 2017;12:e0180911.
    PubMed     Abstract available

  281. CAPORARELLO N, Parrino C, Trischitta V, Frittitta L, et al
    Insulin receptor signaling and glucagon-like peptide 1 effects on pancreatic beta cells.
    PLoS One. 2017;12:e0181190.
    PubMed     Abstract available

  282. XU J, Wang L, Tang J, Jia G, et al
    Pancreatic atrophy caused by dietary selenium deficiency induces hypoinsulinemic hyperglycemia via global down-regulation of selenoprotein encoding genes in broilers.
    PLoS One. 2017;12:e0182079.
    PubMed     Abstract available

  283. MARTINEZ-USEROS J, Georgiev-Hristov T, Fernandez-Acenero MJ, Borrero-Palacios A, et al
    UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
    PLoS One. 2017;12:e0182044.
    PubMed     Abstract available

  284. LEMAIRE K, Granvik M, Schraenen A, Goyvaerts L, et al
    How stable is repression of disallowed genes in pancreatic islets in response to metabolic stress?
    PLoS One. 2017;12:e0181651.
    PubMed     Abstract available

  285. WHATCOTT CJ, Ng S, Barrett MT, Hostetter G, et al
    Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer.
    PLoS One. 2017;12:e0183871.
    PubMed     Abstract available

  286. KOMATSU H, Cook C, Wang CH, Medrano L, et al
    Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival.
    PLoS One. 2017;12:e0183780.
    PubMed     Abstract available

  287. CHEN YJ, Wang WH, Wu WY, Hsu CC, et al
    Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways.
    PLoS One. 2017;12:e0183368.
    PubMed     Abstract available

  288. PERGOLINI I, Morales-Oyarvide V, Mino-Kenudson M, Honselmann KC, et al
    Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
    PLoS One. 2017;12:e0182855.
    PubMed     Abstract available

  289. LEE B, Song T, Lee K, Kim J, et al
    Insulin modulates the frequency of Ca2+ oscillations in mouse pancreatic islets.
    PLoS One. 2017;12:e0183569.
    PubMed     Abstract available

  290. KAWADA Y, Asahara SI, Sugiura Y, Sato A, et al
    Histone deacetylase regulates insulin signaling via two pathways in pancreatic beta cells.
    PLoS One. 2017;12:e0184435.
    PubMed     Abstract available

  291. CHANG HH, Moro A, Takakura K, Su HY, et al
    Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice.
    PLoS One. 2017;12:e0184455.
    PubMed     Abstract available

  292. WEINBERG L, Ianno D, Churilov L, Chao I, et al
    Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial.
    PLoS One. 2017;12:e0183313.
    PubMed     Abstract available

  293. RASCH S, Notzel B, Phillip V, Lahmer T, et al
    Management of pancreatic pseudocysts-A retrospective analysis.
    PLoS One. 2017;12:e0184374.
    PubMed     Abstract available

  294. HELLUM M, Franco-Lie I, Ovstebo R, Hauge T, et al
    The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls.
    PLoS One. 2017;12:e0184579.
    PubMed     Abstract available

  295. WU J, Liu X, Nayak SG, Pitarresi JR, et al
    Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele.
    PLoS One. 2017;12:e0184984.
    PubMed     Abstract available

  296. LAMBERT A, Jarlier M, Gourgou Bourgade S, Conroy T, et al
    Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
    PLoS One. 2017;12:e0183288.
    PubMed     Abstract available

  297. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Abstract available

  298. BRAUSWETTER D, Gurbi B, Varga A, Varkondi E, et al
    Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers.
    PLoS One. 2017;12:e0185687.
    PubMed     Abstract available

  299. CLAWSON GA, Matters GL, Xin P, McGovern C, et al
    "Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.
    PLoS One. 2017;12:e0184451.
    PubMed     Abstract available

  300. ROBERTS FR, Hupple C, Norowski E, Walsh NC, et al
    Possible type 1 diabetes risk prediction: Using ultrasound imaging to assess pancreas inflammation in the inducible autoimmune diabetes BBDR model.
    PLoS One. 2017;12:e0178641.
    PubMed     Abstract available

  301. ZHU Q, Pan X, Sun Y, Wang Z, et al
    Biological nanoparticles carrying the Hmda-7 gene are effective in inhibiting pancreatic cancer in vitro and in vivo.
    PLoS One. 2017;12:e0185507.
    PubMed     Abstract available

  302. VULFIUS CA, Kasheverov IE, Kryukova EV, Spirova EN, et al
    Pancreatic and snake venom presynaptically active phospholipases A2 inhibit nicotinic acetylcholine receptors.
    PLoS One. 2017;12:e0186206.
    PubMed     Abstract available

  303. ZSCHAECK S, Blumke B, Wust P, Kaul D, et al
    Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients.
    PLoS One. 2017;12:e0186341.
    PubMed     Abstract available

  304. KHOSRAWIPOUR T, Khosrawipour V, Giger-Pabst U
    Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma.
    PLoS One. 2017;12:e0186709.
    PubMed     Abstract available

  305. SONG I, Roels S, Martens GA, Bouwens L, et al
    Circulating microRNA-375 as biomarker of pancreatic beta cell death and protection of beta cell mass by cytoprotective compounds.
    PLoS One. 2017;12:e0186480.
    PubMed     Abstract available

  306. FURUKAWA K, Tanemura M, Miyoshi E, Eguchi H, et al
    A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express alpha-gal epitopes.
    PLoS One. 2017;12:e0184901.
    PubMed     Abstract available

  307. XU S, Sun F, Ren L, Yang H, et al
    Resveratrol controlled the fate of porcine pancreatic stem cells through the Wnt/beta-catenin signaling pathway mediated by Sirt1.
    PLoS One. 2017;12:e0187159.
    PubMed     Abstract available

  308. VEITE-SCHMAHL MJ, Rivers AC, Regan DP, Kennedy MA, et al
    The Mouse Model of Pancreatic Cancer Atlas (MMPCA) for classification of pancreatic cancer lesions: A large histological investigation of the Ptf1aCre/+;LSL-KrasG12D/+ transgenic mouse model of pancreatic cancer.
    PLoS One. 2017;12:e0187552.
    PubMed     Abstract available

  309. SANCHO V, Daniele G, Lucchesi D, Lupi R, et al
    Metabolic regulation of GLP-1 and PC1/3 in pancreatic alpha-cell line.
    PLoS One. 2017;12:e0187836.
    PubMed     Abstract available

  310. RIBEIRO D, Andersson EM, Heath N, Persson-Kry A, et al
    Human pancreatic islet-derived extracellular vesicles modulate insulin expression in 3D-differentiating iPSC clusters.
    PLoS One. 2017;12:e0187665.
    PubMed     Abstract available

  311. GARG PK, Lokitz SJ, Truong L, Putegnat B, et al
    Pancreatic uptake and radiation dosimetry of 6-[18F]fluoro-L-DOPA from PET imaging studies in infants with congenital hyperinsulinism.
    PLoS One. 2017;12:e0186340.
    PubMed     Abstract available

  312. CEN D, Chen J, Li Z, Zhao J, et al
    Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis.
    PLoS One. 2017;12:e0187588.
    PubMed     Abstract available

  313. MIYAZAWA M, Takatori H, Shimakami T, Kawaguchi K, et al
    Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
    PLoS One. 2017;12:e0188549.
    PubMed     Abstract available

  314. XIA T, Chai X, Shen J
    Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss.
    PLoS One. 2017;12:e0187804.
    PubMed     Abstract available

  315. PULS TJ, Tan X, Whittington CF, Voytik-Harbin SL, et al
    3D collagen fibrillar microstructure guides pancreatic cancer cell phenotype and serves as a critical design parameter for phenotypic models of EMT.
    PLoS One. 2017;12:e0188870.
    PubMed     Abstract available

  316. BRUNO W, Andreotti V, Bisio A, Pastorino L, et al
    Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development.
    PLoS One. 2017;12:e0189123.
    PubMed     Abstract available

  317. CHAKRABORTY J, Langdon-Embry L, Cunanan KM, Escalon JG, et al
    Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients.
    PLoS One. 2017;12:e0188022.
    PubMed     Abstract available

  318. SAISON-RIDINGER M, DelGiorno KE, Zhang T, Kraus A, et al
    Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy.
    PLoS One. 2017;12:e0189051.
    PubMed     Abstract available

  319. HAN X, Xu Z, Cao S, Zhao Y, et al
    The effect of somatostatin analogues on postoperative outcomes following pancreatic surgery: A meta-analysis.
    PLoS One. 2017;12:e0188928.
    PubMed     Abstract available

  320. ELLIOTT AD, Bedard N, Ustione A, Baird MA, et al
    Hyperspectral imaging for simultaneous measurements of two FRET biosensors in pancreatic beta-cells.
    PLoS One. 2017;12:e0188789.
    PubMed     Abstract available

  321. LIU S, Li X, Wu Y, Duan R, et al
    Effects of vaspin on pancreatic beta cell secretion via PI3K/Akt and NF-kappaB signaling pathways.
    PLoS One. 2017;12:e0189722.
    PubMed     Abstract available

  322. GURUSAMY KS, Riviere D, van Laarhoven CJH, Besselink M, et al
    Cost-effectiveness of laparoscopic versus open distal pancreatectomy for pancreatic cancer.
    PLoS One. 2017;12:e0189631.
    PubMed     Abstract available

    January 2016
  323. PLAISANCE V, Brajkovic S, Tenenbaum M, Favre D, et al
    Endoplasmic Reticulum Stress Links Oxidative Stress to Impaired Pancreatic Beta-Cell Function Caused by Human Oxidized LDL.
    PLoS One. 2016;11:e0163046.
    PubMed     Abstract available

  324. SHIN SH, Kim SC, Song KB, Hwang DW, et al
    Appraisal of Laparoscopic Distal Pancreatectomy for Left-Sided Pancreatic Cancer: A Large Volume Cohort Study of 152 Consecutive Patients.
    PLoS One. 2016;11:e0163266.
    PubMed     Abstract available

  325. SALMIHEIMO A, Mustonen H, Stenman UH, Puolakkainen P, et al
    Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma.
    PLoS One. 2016;11:e0163064.
    PubMed     Abstract available

  326. KONG F, Zhu J, Kong X, Sun T, et al
    Rapid On-Site Evaluation Does Not Improve Endoscopic Ultrasound-Guided Fine Needle Aspiration Adequacy in Pancreatic Masses: A Meta-Analysis and Systematic Review.
    PLoS One. 2016;11:e0163056.
    PubMed     Abstract available

  327. RASCH S, Phillip V, Reichel S, Rau B, et al
    Open Surgical versus Minimal Invasive Necrosectomy of the Pancreas-A Retrospective Multicenter Analysis of the German Pancreatitis Study Group.
    PLoS One. 2016;11:e0163651.
    PubMed     Abstract available

  328. SAITOH I, Sato M, Soda M, Inada E, et al
    Tissue-Specific Stem Cells Obtained by Reprogramming of Non-Obese Diabetic (NOD) Mouse-Derived Pancreatic Cells Confer Insulin Production in Response to Glucose.
    PLoS One. 2016;11:e0163580.
    PubMed     Abstract available

  329. PENG YP, Zhu Y, Yin LD, Zhang JJ, et al
    The Expression and Prognostic Roles of MCMs in Pancreatic Cancer.
    PLoS One. 2016;11:e0164150.
    PubMed     Abstract available

  330. AHN C, Lee D, Lee JH, Yang H, et al
    Calbindin-D9k Ablation Disrupt Glucose/Pancreatic Insulin Homeostasis.
    PLoS One. 2016;11:e0164527.
    PubMed     Abstract available

  331. DREHER C, Scholz C, Pommer M, Brons S, et al
    Optimization of Carbon Ion Treatment Plans by Integrating Tissue Specific alpha/beta-Values for Patients with Non-Resectable Pancreatic Cancer.
    PLoS One. 2016;11:e0164473.
    PubMed     Abstract available

  332. DAL MOLIN M, Brant A, Blackford AL, Griffin JF, et al
    Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma.
    PLoS One. 2016;11:e0164195.
    PubMed     Abstract available

  333. WANG SH, Chou YC, Shangkuan WC, Wei KY, et al
    Relationship between Plasma Triglyceride Level and Severity of Hypertriglyceridemic Pancreatitis.
    PLoS One. 2016;11:e0163984.
    PubMed     Abstract available

  334. WODZIAK D, Dong A, Basin MF, Lowe AW, et al
    Anterior Gradient 2 (AGR2) Induced Epidermal Growth Factor Receptor (EGFR) Signaling Is Essential for Murine Pancreatitis-Associated Tissue Regeneration.
    PLoS One. 2016;11:e0164968.
    PubMed     Abstract available

  335. POLIREDDY K, Dong R, McDonald PR, Wang T, et al
    Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation.
    PLoS One. 2016;11:e0164811.
    PubMed     Abstract available

  336. LI X, Zhuang L, Zhang X, Wang J, et al
    Correction: Preliminary Study of MR Diffusion Tensor Imaging of Pancreas for the Diagnosis of Acute Pancreatitis.
    PLoS One. 2016;11:e0165353.
    PubMed     Abstract available

  337. MA YC, Wang ZX, Jin SJ, Zhang YX, et al
    Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.
    PLoS One. 2016;11:e0162821.
    PubMed     Abstract available

  338. BAPAT AA, Munoz RM, Von Hoff DD, Han H, et al
    Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells.
    PLoS One. 2016;11:e0165586.
    PubMed     Abstract available

  339. SCHIMMACK S, Kneller S, Dadabaeva N, Bergmann F, et al
    Epithelial to Stromal Re-Distribution of Primary Cilia during Pancreatic Carcinogenesis.
    PLoS One. 2016;11:e0164231.
    PubMed     Abstract available

  340. SZENTESI A, Toth E, Balint E, Fanczal J, et al
    Analysis of Research Activity in Gastroenterology: Pancreatitis Is in Real Danger.
    PLoS One. 2016;11:e0165244.
    PubMed     Abstract available

  341. BALZANO G, Dugnani E, Gandolfi A, Scavini M, et al
    Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study.
    PLoS One. 2016;11:e0166008.
    PubMed     Abstract available

  342. HENQUIN JC, Nenquin M
    Dynamics and Regulation of Insulin Secretion in Pancreatic Islets from Normal Young Children.
    PLoS One. 2016;11:e0165961.
    PubMed     Abstract available

  343. FJELD K, Beer S, Johnstone M, Zimmer C, et al
    Length of Variable Numbers of Tandem Repeats in the Carboxyl Ester Lipase (CEL) Gene May Confer Susceptibility to Alcoholic Liver Cirrhosis but Not Alcoholic Chronic Pancreatitis.
    PLoS One. 2016;11:e0165567.
    PubMed     Abstract available

  344. PARNICZKY A, Kui B, Szentesi A, Balazs A, et al
    Prospective, Multicentre, Nationwide Clinical Data from 600 Cases of Acute Pancreatitis.
    PLoS One. 2016;11:e0165309.
    PubMed     Abstract available

  345. GAZIOVA I, Jackson D, Boor PJ, Carter D, et al
    The MET Receptor Tyrosine Kinase Confers Repair of Murine Pancreatic Acinar Cells following Acute and Chronic Injury.
    PLoS One. 2016;11:e0165485.
    PubMed     Abstract available

  346. DE LEON-BAUTISTA MP, Cardenas-Aguayo MD, Casique-Aguirre D, Almaraz-Salinas M, et al
    Immunological and Functional Characterization of RhoGDI3 and Its Molecular Targets RhoG and RhoB in Human Pancreatic Cancerous and Normal Cells.
    PLoS One. 2016;11:e0166370.
    PubMed     Abstract available

  347. VAN ROEST MH, van der Aa MA, van der Geest LG, de Jong KP, et al
    The Impact of Socioeconomic Status, Surgical Resection and Type of Hospital on Survival in Patients with Pancreatic Cancer. A Population-Based Study in The Netherlands.
    PLoS One. 2016;11:e0166449.
    PubMed     Abstract available

  348. SHENOY VK, Beaver KM, Fisher FM, Singhal G, et al
    Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis.
    PLoS One. 2016;11:e0164351.
    PubMed     Abstract available

  349. CAO S, Hu Y, Gao X, Liao Q, et al
    Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis.
    PLoS One. 2016;11:e0166406.
    PubMed     Abstract available

  350. HE M, Qiao Z, Wang Y, Kuai Q, et al
    Chidamide Inhibits Aerobic Metabolism to Induce Pancreatic Cancer Cell Growth Arrest by Promoting Mcl-1 Degradation.
    PLoS One. 2016;11:e0166896.
    PubMed     Abstract available

  351. YIN Y, Yong W, Yu J, Zhang X, et al
    Pdcd2l Promotes Palmitate-Induced Pancreatic Beta-Cell Apoptosis as a FoxO1 Target Gene.
    PLoS One. 2016;11:e0166692.
    PubMed     Abstract available

  352. SCHAWKAT K, Kuhn W, Inderbitzin D, Gloor B, et al
    Diagnostic Value and Interreader Agreement of the Pancreaticolienal Gap in Pancreatic Cancer on MDCT.
    PLoS One. 2016;11:e0166003.
    PubMed     Abstract available

  353. MAHMUD M, Piwoni A, Filiczak N, Janicka M, et al
    Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
    PLoS One. 2016;11:e0167787.
    PubMed     Abstract available

  354. OTA S, Nishimura M, Murakami Y, Birukawa NK, et al
    Involvement of Pancreatic Stellate Cells in Regeneration of Remnant Pancreas after Partial Pancreatectomy.
    PLoS One. 2016;11:e0165747.
    PubMed     Abstract available

  355. HUANG X, Knoble JL, Zeng M, Aguila FN, et al
    Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients.
    PLoS One. 2016;11:e0166606.
    PubMed     Abstract available

  356. BHAT N, Park J, Zoghbi HY, Arthur JS, et al
    The Chromatin Modifier MSK1/2 Suppresses Endocrine Cell Fates during Mouse Pancreatic Development.
    PLoS One. 2016;11:e0166703.
    PubMed     Abstract available

  357. LOHSE I, Kumareswaran R, Cao P, Pitcher B, et al
    Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts.
    PLoS One. 2016;11:e0167272.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.